1 Study Coverage
1.1 Non-opioid Analgesics Product Introduction
1.2 Market by Type
1.2.1 Global Non-opioid Analgesics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Local Anesthetics
1.3 Market by Distribution Channel
1.3.1 Global Non-opioid Analgesics Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-opioid Analgesics Sales Estimates and Forecasts 2017-2028
2.2 Global Non-opioid Analgesics Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-opioid Analgesics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-opioid Analgesics Sales by Region
2.4.1 Global Non-opioid Analgesics Sales by Region (2017-2022)
2.4.2 Global Sales Non-opioid Analgesics by Region (2023-2028)
2.5 Global Non-opioid Analgesics Revenue by Region
2.5.1 Global Non-opioid Analgesics Revenue by Region (2017-2022)
2.5.2 Global Non-opioid Analgesics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-opioid Analgesics Sales by Manufacturers
3.1.1 Global Top Non-opioid Analgesics Manufacturers by Sales (2017-2022)
3.1.2 Global Non-opioid Analgesics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-opioid Analgesics in 2021
3.2 Global Non-opioid Analgesics Revenue by Manufacturers
3.2.1 Global Non-opioid Analgesics Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-opioid Analgesics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-opioid Analgesics Revenue in 2021
3.3 Global Non-opioid Analgesics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-opioid Analgesics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-opioid Analgesics Sales by Type
4.1.1 Global Non-opioid Analgesics Historical Sales by Type (2017-2022)
4.1.2 Global Non-opioid Analgesics Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-opioid Analgesics Sales Market Share by Type (2017-2028)
4.2 Global Non-opioid Analgesics Revenue by Type
4.2.1 Global Non-opioid Analgesics Historical Revenue by Type (2017-2022)
4.2.2 Global Non-opioid Analgesics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
4.3 Global Non-opioid Analgesics Price by Type
4.3.1 Global Non-opioid Analgesics Price by Type (2017-2022)
4.3.2 Global Non-opioid Analgesics Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global Non-opioid Analgesics Sales by Distribution Channel
5.1.1 Global Non-opioid Analgesics Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global Non-opioid Analgesics Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
5.2 Global Non-opioid Analgesics Revenue by Distribution Channel
5.2.1 Global Non-opioid Analgesics Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global Non-opioid Analgesics Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global Non-opioid Analgesics Price by Distribution Channel
5.3.1 Global Non-opioid Analgesics Price by Distribution Channel (2017-2022)
5.3.2 Global Non-opioid Analgesics Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America Non-opioid Analgesics Market Size by Type
6.1.1 North America Non-opioid Analgesics Sales by Type (2017-2028)
6.1.2 North America Non-opioid Analgesics Revenue by Type (2017-2028)
6.2 North America Non-opioid Analgesics Market Size by Distribution Channel
6.2.1 North America Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
6.2.2 North America Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
6.3 North America Non-opioid Analgesics Market Size by Country
6.3.1 North America Non-opioid Analgesics Sales by Country (2017-2028)
6.3.2 North America Non-opioid Analgesics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Non-opioid Analgesics Market Size by Type
7.1.1 Europe Non-opioid Analgesics Sales by Type (2017-2028)
7.1.2 Europe Non-opioid Analgesics Revenue by Type (2017-2028)
7.2 Europe Non-opioid Analgesics Market Size by Distribution Channel
7.2.1 Europe Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
7.2.2 Europe Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
7.3 Europe Non-opioid Analgesics Market Size by Country
7.3.1 Europe Non-opioid Analgesics Sales by Country (2017-2028)
7.3.2 Europe Non-opioid Analgesics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-opioid Analgesics Market Size by Type
8.1.1 Asia Pacific Non-opioid Analgesics Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-opioid Analgesics Revenue by Type (2017-2028)
8.2 Asia Pacific Non-opioid Analgesics Market Size by Distribution Channel
8.2.1 Asia Pacific Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific Non-opioid Analgesics Market Size by Region
8.3.1 Asia Pacific Non-opioid Analgesics Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-opioid Analgesics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Non-opioid Analgesics Market Size by Type
9.1.1 Latin America Non-opioid Analgesics Sales by Type (2017-2028)
9.1.2 Latin America Non-opioid Analgesics Revenue by Type (2017-2028)
9.2 Latin America Non-opioid Analgesics Market Size by Distribution Channel
9.2.1 Latin America Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
9.2.2 Latin America Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
9.3 Latin America Non-opioid Analgesics Market Size by Country
9.3.1 Latin America Non-opioid Analgesics Sales by Country (2017-2028)
9.3.2 Latin America Non-opioid Analgesics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-opioid Analgesics Market Size by Type
10.1.1 Middle East and Africa Non-opioid Analgesics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-opioid Analgesics Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-opioid Analgesics Market Size by Distribution Channel
10.2.1 Middle East and Africa Non-opioid Analgesics Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa Non-opioid Analgesics Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa Non-opioid Analgesics Market Size by Country
10.3.1 Middle East and Africa Non-opioid Analgesics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-opioid Analgesics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Overview
11.1.3 AbbVie Inc Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Inc Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Inc Recent Developments
11.2 Pfizer, Inc
11.2.1 Pfizer, Inc Corporation Information
11.2.2 Pfizer, Inc Overview
11.2.3 Pfizer, Inc Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer, Inc Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer, Inc Recent Developments
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.3.2 Teva Pharmaceutical Industries Ltd. Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.4 Viatris Inc.
11.4.1 Viatris Inc. Corporation Information
11.4.2 Viatris Inc. Overview
11.4.3 Viatris Inc. Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Viatris Inc. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Inc. Recent Developments
11.5 Centrexion Therapeutics
11.5.1 Centrexion Therapeutics Corporation Information
11.5.2 Centrexion Therapeutics Overview
11.5.3 Centrexion Therapeutics Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Centrexion Therapeutics Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Centrexion Therapeutics Recent Developments
11.6 Cara Therapeutics
11.6.1 Cara Therapeutics Corporation Information
11.6.2 Cara Therapeutics Overview
11.6.3 Cara Therapeutics Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cara Therapeutics Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cara Therapeutics Recent Developments
11.7 Medropharm GmbH.
11.7.1 Medropharm GmbH. Corporation Information
11.7.2 Medropharm GmbH. Overview
11.7.3 Medropharm GmbH. Non-opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medropharm GmbH. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medropharm GmbH. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-opioid Analgesics Industry Chain Analysis
12.2 Non-opioid Analgesics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-opioid Analgesics Production Mode & Process
12.4 Non-opioid Analgesics Sales and Marketing
12.4.1 Non-opioid Analgesics Sales Channels
12.4.2 Non-opioid Analgesics Distributors
12.5 Non-opioid Analgesics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-opioid Analgesics Industry Trends
13.2 Non-opioid Analgesics Market Drivers
13.3 Non-opioid Analgesics Market Challenges
13.4 Non-opioid Analgesics Market Restraints
14 Key Findings in The Global Non-opioid Analgesics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Non-opioid Analgesics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of NSAIDs
Table 3. Major Manufacturers of Acetaminophen
Table 4. Major Manufacturers of Local Anesthetics
Table 5. Global Non-opioid Analgesics Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Non-opioid Analgesics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Non-opioid Analgesics Sales by Region (2017-2022) & (K Units)
Table 8. Global Non-opioid Analgesics Sales Market Share by Region (2017-2022)
Table 9. Global Non-opioid Analgesics Sales by Region (2023-2028) & (K Units)
Table 10. Global Non-opioid Analgesics Sales Market Share by Region (2023-2028)
Table 11. Global Non-opioid Analgesics Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Non-opioid Analgesics Revenue Market Share by Region (2017-2022)
Table 13. Global Non-opioid Analgesics Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Non-opioid Analgesics Revenue Market Share by Region (2023-2028)
Table 15. Global Non-opioid Analgesics Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Non-opioid Analgesics Sales Share by Manufacturers (2017-2022)
Table 17. Global Non-opioid Analgesics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Non-opioid Analgesics Revenue Share by Manufacturers (2017-2022)
Table 19. Non-opioid Analgesics Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Non-opioid Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Non-opioid Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Analgesics as of 2021)
Table 22. Non-opioid Analgesics Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Non-opioid Analgesics Product Offered
Table 24. Date of Manufacturers Enter into Non-opioid Analgesics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-opioid Analgesics Sales by Type (2017-2022) & (K Units)
Table 27. Global Non-opioid Analgesics Sales by Type (2023-2028) & (K Units)
Table 28. Global Non-opioid Analgesics Sales Share by Type (2017-2022)
Table 29. Global Non-opioid Analgesics Sales Share by Type (2023-2028)
Table 30. Global Non-opioid Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Non-opioid Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Non-opioid Analgesics Revenue Share by Type (2017-2022)
Table 33. Global Non-opioid Analgesics Revenue Share by Type (2023-2028)
Table 34. Non-opioid Analgesics Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Non-opioid Analgesics Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Non-opioid Analgesics Sales by Distribution Channel (2017-2022) & (K Units)
Table 37. Global Non-opioid Analgesics Sales by Distribution Channel (2023-2028) & (K Units)
Table 38. Global Non-opioid Analgesics Sales Share by Distribution Channel (2017-2022)
Table 39. Global Non-opioid Analgesics Sales Share by Distribution Channel (2023-2028)
Table 40. Global Non-opioid Analgesics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 41. Global Non-opioid Analgesics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 42. Global Non-opioid Analgesics Revenue Share by Distribution Channel (2017-2022)
Table 43. Global Non-opioid Analgesics Revenue Share by Distribution Channel (2023-2028)
Table 44. Non-opioid Analgesics Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 45. Global Non-opioid Analgesics Price Forecast by Distribution Channel (2023-2028) & (US$/Unit)
Table 46. North America Non-opioid Analgesics Sales by Type (2017-2022) & (K Units)
Table 47. North America Non-opioid Analgesics Sales by Type (2023-2028) & (K Units)
Table 48. North America Non-opioid Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Non-opioid Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Non-opioid Analgesics Sales by Distribution Channel (2017-2022) & (K Units)
Table 51. North America Non-opioid Analgesics Sales by Distribution Channel (2023-2028) & (K Units)
Table 52. North America Non-opioid Analgesics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 53. North America Non-opioid Analgesics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 54. North America Non-opioid Analgesics Sales by Country (2017-2022) & (K Units)
Table 55. North America Non-opioid Analgesics Sales by Country (2023-2028) & (K Units)
Table 56. North America Non-opioid Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Non-opioid Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Non-opioid Analgesics Sales by Type (2017-2022) & (K Units)
Table 59. Europe Non-opioid Analgesics Sales by Type (2023-2028) & (K Units)
Table 60. Europe Non-opioid Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Non-opioid Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Non-opioid Analgesics Sales by Distribution Channel (2017-2022) & (K Units)
Table 63. Europe Non-opioid Analgesics Sales by Distribution Channel (2023-2028) & (K Units)
Table 64. Europe Non-opioid Analgesics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 65. Europe Non-opioid Analgesics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 66. Europe Non-opioid Analgesics Sales by Country (2017-2022) & (K Units)
Table 67. Europe Non-opioid Analgesics Sales by Country (2023-2028) & (K Units)
Table 68. Europe Non-opioid Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Non-opioid Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Non-opioid Analgesics Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Non-opioid Analgesics Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Non-opioid Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Non-opioid Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Non-opioid Analgesics Sales by Distribution Channel (2017-2022) & (K Units)
Table 75. Asia Pacific Non-opioid Analgesics Sales by Distribution Channel (2023-2028) & (K Units)
Table 76. Asia Pacific Non-opioid Analgesics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 77. Asia Pacific Non-opioid Analgesics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 78. Asia Pacific Non-opioid Analgesics Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Non-opioid Analgesics Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Non-opioid Analgesics Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Non-opioid Analgesics Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Non-opioid Analgesics Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Non-opioid Analgesics Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Non-opioid Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Non-opioid Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Non-opioid Analgesics Sales by Distribution Channel (2017-2022) & (K Units)
Table 87. Latin America Non-opioid Analgesics Sales by Distribution Channel (2023-2028) & (K Units)
Table 88. Latin America Non-opioid Analgesics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 89. Latin America Non-opioid Analgesics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 90. Latin America Non-opioid Analgesics Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Non-opioid Analgesics Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Non-opioid Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Non-opioid Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Non-opioid Analgesics Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Non-opioid Analgesics Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Non-opioid Analgesics Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Non-opioid Analgesics Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Non-opioid Analgesics Sales by Distribution Channel (2017-2022) & (K Units)
Table 99. Middle East and Africa Non-opioid Analgesics Sales by Distribution Channel (2023-2028) & (K Units)
Table 100. Middle East and Africa Non-opioid Analgesics Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Non-opioid Analgesics Revenue by Distribution Channel (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Non-opioid Analgesics Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Non-opioid Analgesics Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Non-opioid Analgesics Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Non-opioid Analgesics Revenue by Country (2023-2028) & (US$ Million)
Table 106. AbbVie Inc Corporation Information
Table 107. AbbVie Inc Description and Major Businesses
Table 108. AbbVie Inc Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. AbbVie Inc Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. AbbVie Inc Recent Developments
Table 111. Pfizer, Inc Corporation Information
Table 112. Pfizer, Inc Description and Major Businesses
Table 113. Pfizer, Inc Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Pfizer, Inc Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer, Inc Recent Developments
Table 116. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 117. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 118. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 121. Viatris Inc. Corporation Information
Table 122. Viatris Inc. Description and Major Businesses
Table 123. Viatris Inc. Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Viatris Inc. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Viatris Inc. Recent Developments
Table 126. Centrexion Therapeutics Corporation Information
Table 127. Centrexion Therapeutics Description and Major Businesses
Table 128. Centrexion Therapeutics Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Centrexion Therapeutics Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Centrexion Therapeutics Recent Developments
Table 131. Cara Therapeutics Corporation Information
Table 132. Cara Therapeutics Description and Major Businesses
Table 133. Cara Therapeutics Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Cara Therapeutics Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Cara Therapeutics Recent Developments
Table 136. Medropharm GmbH. Corporation Information
Table 137. Medropharm GmbH. Description and Major Businesses
Table 138. Medropharm GmbH. Non-opioid Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Medropharm GmbH. Non-opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Medropharm GmbH. Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Non-opioid Analgesics Distributors List
Table 144. Non-opioid Analgesics Customers List
Table 145. Non-opioid Analgesics Market Trends
Table 146. Non-opioid Analgesics Market Drivers
Table 147. Non-opioid Analgesics Market Challenges
Table 148. Non-opioid Analgesics Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-opioid Analgesics Product Picture
Figure 2. Global Non-opioid Analgesics Market Share by Type in 2021 & 2028
Figure 3. NSAIDs Product Picture
Figure 4. Acetaminophen Product Picture
Figure 5. Local Anesthetics Product Picture
Figure 6. Global Non-opioid Analgesics Market Share by Distribution Channel in 2021 & 2028
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Non-opioid Analgesics Report Years Considered
Figure 11. Global Non-opioid Analgesics Sales 2017-2028 (K Units)
Figure 12. Global Non-opioid Analgesics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Non-opioid Analgesics Revenue 2017-2028 (US$ Million)
Figure 14. Global Non-opioid Analgesics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Non-opioid Analgesics Sales Market Share by Region (2017-2022)
Figure 16. Global Non-opioid Analgesics Sales Market Share by Region (2023-2028)
Figure 17. North America Non-opioid Analgesics Sales YoY (2017-2028) & (K Units)
Figure 18. North America Non-opioid Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Non-opioid Analgesics Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Non-opioid Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Non-opioid Analgesics Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Non-opioid Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Non-opioid Analgesics Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Non-opioid Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Non-opioid Analgesics Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Non-opioid Analgesics Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Non-opioid Analgesics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Non-opioid Analgesics in the World: Market Share by Non-opioid Analgesics Revenue in 2021
Figure 29. Global Non-opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Non-opioid Analgesics Sales Market Share by Type (2017-2028)
Figure 31. Global Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
Figure 32. Global Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
Figure 33. Global Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
Figure 34. North America Non-opioid Analgesics Sales Market Share by Type (2017-2028)
Figure 35. North America Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
Figure 36. North America Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
Figure 37. North America Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
Figure 38. North America Non-opioid Analgesics Sales Share by Country (2017-2028)
Figure 39. North America Non-opioid Analgesics Revenue Share by Country (2017-2028)
Figure 40. United States Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Non-opioid Analgesics Sales Market Share by Type (2017-2028)
Figure 43. Europe Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
Figure 44. Europe Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
Figure 45. Europe Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
Figure 46. Europe Non-opioid Analgesics Sales Share by Country (2017-2028)
Figure 47. Europe Non-opioid Analgesics Revenue Share by Country (2017-2028)
Figure 48. Germany Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 49. France Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Non-opioid Analgesics Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
Figure 56. Asia Pacific Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
Figure 57. Asia Pacific Non-opioid Analgesics Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Non-opioid Analgesics Revenue Share by Region (2017-2028)
Figure 59. China Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 62. India Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Non-opioid Analgesics Sales Market Share by Type (2017-2028)
Figure 69. Latin America Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
Figure 71. Latin America Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
Figure 72. Latin America Non-opioid Analgesics Sales Share by Country (2017-2028)
Figure 73. Latin America Non-opioid Analgesics Revenue Share by Country (2017-2028)
Figure 74. Mexico Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Non-opioid Analgesics Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Non-opioid Analgesics Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Non-opioid Analgesics Sales Market Share by Distribution Channel (2017-2028)
Figure 80. Middle East and Africa Non-opioid Analgesics Revenue Market Share by Distribution Channel (2017-2028)
Figure 81. Middle East and Africa Non-opioid Analgesics Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Non-opioid Analgesics Revenue Share by Country (2017-2028)
Figure 83. Turkey Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Non-opioid Analgesics Revenue (2017-2028) & (US$ Million)
Figure 86. Non-opioid Analgesics Value Chain
Figure 87. Non-opioid Analgesics Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed